Mixed Herbal Extract Anticancer Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments face challenges due to high toxicity and inability to selectively target cancer cells, necessitating the development of anticancer agents with low toxicity that can effectively inhibit cancer cell proliferation and metastasis without affecting normal cell growth.
Innovation Solution
A composition featuring a mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii, which is extracted using a solvent and formulated into pharmaceutical or food compositions, specifically inhibiting cancer cell proliferation and metastasis while sparing normal cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional cancer medicines are used, then cancer cells can be removed, but normal cells are also damaged due to high toxicity
Solution Approach 1:
The invention segments the anticancer effect into multiple independent herbal components (Astragalus membranaceus, Angelica gigas, Trichosanthes kirilowii) that work synergistically. Each herb contributes specific bioactive compounds that target cancer cells through different mechanisms, allowing the composition to achieve selective toxicity against cancer cells while sparing normal cells through the combined action of these segmented components.
Solution Approach 2:
The invention creates a composite herbal composition combining three traditional Korean medicines in specific proportions. This composite material leverages the synergistic effects of different herbal extracts, where the combination produces enhanced anticancer activity and selectivity that exceeds the sum of individual components, effectively resolving the toxicity-selectivity contradiction.
2Reliability
If single-herb extracts are used, then specific traditional effects are achieved, but anticancer efficacy is insufficient
Solution Approach 1:
The invention merges three separate herbal extracts (Astragalus membranaceus at 60-80%, Angelica gigas at 10-30%, Trichosanthes kirilowii at 10-30%) into a unified composition. This combination consolidates the anticancer effects of multiple herbs while maintaining their individual contributions, achieving superior efficacy through synergistic interaction without excessive complexity.
Solution Approach 2:
The herbal composition exhibits multi-functionality by simultaneously achieving multiple objectives: inhibiting cancer cell proliferation, inducing apoptosis, preventing metastasis, and enhancing immune response. This universal approach allows a single composition to address various aspects of cancer pathology, reducing the need for multiple separate treatments.
Data Source
AI summary
The present invention relates to a composition containing, as an active ingredient, a mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii, for preventing or treating cancer. The mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii according to the present invention does not impact normal cell growth, while having an anticancer effect which specifically inhibits the proliferation of cancer cells, and an excellent effect of inhibiting metastasis of cancer cells, and thus can be useful in preventing or treating cancer and supplementing cancer treatment.